During the administration of Methylergometrine, what adverse reactions should be monitored?

Enhance your preparation for the ATI Comprehensive Predictor Exam with our retake test. Dive into interactive questions with detailed explanations to boost your confidence and increase your chances of success!

Monitoring for nausea, vomiting, and hypertension during the administration of Methylergometrine is essential due to the medication's pharmacological effects. Methylergometrine is an ergot alkaloid used to prevent or control postpartum hemorrhage by causing the uterus to contract. One of the common adverse reactions associated with this medication is gastrointestinal disturbance, which often presents as nausea and vomiting.

Additionally, Methylergometrine can lead to an increase in blood pressure due to its vasoconstrictive properties, potentially causing hypertension. This risk is particularly significant in patients with a history of hypertensive disorders. Thus, it is critical to monitor the patient's blood pressure and assess for any gastrointestinal symptoms to ensure patient safety and manage any adverse effects promptly.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy